Major League Soccer Commissioner Don Garber says the league continues to look at shifting to a fall-to-spring season, saying he’d “rather get it right and take our time than get it wrong and ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf ...

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- Investors in Replimune Group, a biotechnology company focused on cancer treatments, witnessed a dramatic collapse in their holdings on July 22. Shares ...

Vir Biotechnology has a strong cash position and is poised to generate definitive data in antivirals and oncology, making ...

Iova stock jumps 31% amid FDA setback for rival, short squeeze buzz, and rising momentum for Amtagvi melanoma therapy.

Replimune (REPL) stock rebounds even as FDA rejection of its RP1 skin cancer drug lead to multiple analyst downgrades on Wall Street. Read more here.

Kennedy Jr. sued him in his capacity as HHS secretary for not establishing a task force to promote the development of safer ...

Fintel reports that on July 22, 2025, Leerink Partners downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Outperform to Market Perform. Analyst Price Forecast Suggests 725.97% Upside As ...

Fintel reports that on July 23, 2025, Barclays downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 725.97% Upside As of July ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Northern Trust Corp (NTRS) is expected to report $2.05 for 2Q. Otis Worldwide Corp (OTIS) is expected to report $0.93 for 2Q. PROG Holdings Inc (PRG) is expected to report $0.74 for 2Q. Pacific ...